Latest filing published 17 Dec 2007 for PANACOS PHARMACEUTICALS, INC., €6,095.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -83.1%Entry 0.83 · Close at T+365 0.14
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
David E. Martin: trading record in brief
David E. Martin is a declared insider of Panacos Pharmaceuticals, Inc., with filings sourced from SEC (Form 4). In total, 2 filings cover trades dated from 2 November 2007 to 14 December 2007.
The open-market record is one-sided, with 1 purchase worth €6,095 and not one sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 1 share grant.
The latest filing, published on 17 December 2007, reports an open-market purchase of €6,095 in Panacos Pharmaceuticals, Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to David E. Martin
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 10,000 shares@ US$0.88Common StockSEC:0001181431-07-075781:0Canonical exit: 13 Mar 2008 (T+90)
- 25,000 shares0Common StockSEC:0001181431-07-066812:0
2 of 2 declarations
